Threshold Pharma (THLD) Posts Q4 Loss of 12c/Share

Threshold Pharma (NASDAQ: THLD) reported Q4 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $4.1 million.

For earnings history and earnings-related data on Threshold Pharma (THLD) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
• Hyperion DeFi (HYPD) Tops Q2 EPS by 57c